Recent Advances in Understanding the Role of IKKβ in Cardiometabolic Diseases

Area of Science:

• Molecular biology
• Immunology
• Metabolic diseases

Background:

• Cardiometabolic diseases (cardiovascular disease, obesity, diabetes) are leading global health issues.
• These diseases involve overlapping metabolic syndromes like hypertension, hyperlipidemia, insulin resistance, and central adiposity.
• The precise causes of cardiometabolic diseases and their associated syndromes are not fully understood.

Purpose of the Study:

• To review the role of IκB kinase β (IKKβ) in cardiometabolic diseases.
• To summarize current knowledge on IKKβ's functions in disease development and progression.
• To highlight IKKβ as a potential therapeutic target.

Main Methods:

• Review of recent scientific literature on IKKβ and cardiometabolic diseases.
• Analysis of IKKβ's involvement in inflammatory signaling pathways.
• Examination of IKKβ's roles in adiposity, insulin sensitivity, glucose homeostasis, vascular function, and atherogenesis.

Main Results:

• Nuclear factor-kappa B (NF-κB) is highly active in cardiometabolic diseases.
• IκB kinase β (IKKβ) is essential for NF-κB activation and links inflammation to cardiometabolic diseases.
• IKKβ plays diverse roles in adiposity, insulin sensitivity, glucose homeostasis, vascular function, and atherogenesis.

Conclusions:

• IKKβ is a critical mediator in the development and progression of cardiometabolic diseases.
• IKKβ represents a promising therapeutic target for cardiometabolic diseases.
• Further research into IKKβ's complex mechanisms is warranted.